Combination treatment alteration methods and systems

• US 20090270692A1
• Filed: 05/21/2008
• Published: 10/29/2009
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Granted Patent: US 7,974,787 B2
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: A61B 5/00 Measuring for diagnostic purposes radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00; Identification of persons
• CPC Class Codes: A61B 5/02 Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/05 Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves impedance plethysmography A61B5/0295; measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/082 Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath A61B5/083, A61B5/091 take precedence
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 5/4266 sweat secretion
• CPC Class Codes: A61B 5/4839 combined with drug delivery

Abstract

Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent.

Claims

1. A computer-implemented method comprising:

detecting at least one indication of bioactive agent use by an individual; and

altering an artificial sensory experience to modify at least one effect of the bioactive agent.

2-31. -31. (canceled)

32. A system comprising:

means for detecting at least one indication of bioactive agent use by an individual; and

means for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

33. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual.

34. The system of claim 33 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:

means for analyzing brain activity using at least one of near infra-red imaging, EEG, magnetoencephalography, functional magnetic resonance imaging, or computer-aided tomography.

35. The system of claim 33 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:

means for detecting at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight modifying drug, a neurodegenerative disorder medication, or a vascular disease medication as the at least one medication.

36. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting a concentration of the bioactive agent in the individual.

37. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for comparing a measured value of the bioactive agent in the individual to a stored baseline value of the bioactive agent for the individual to identify a differential indicative of bioactive agent use.

38. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting substance use by the individual.

39. The system of claim 38 wherein the means for detecting substance use by the individual comprises:

means for detecting at least one of alcohol use, psychoactive drug use, tranquilizer use, methamphetamine use, or narcotic use.

40. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting a nutraceutical used by the individual.

41. The system of claim 40 wherein the means for detecting a nutraceutical used by the individual comprises:

means for detecting at least one of a memory supplement, an anti-oxidant, a cancer preventative, or a mood-changing agent.

42. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting at least one indication of bioactive agent use by at least one of a computer game participant, a social networking website participant, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

43. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent.

44. The system of claim 43 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for restricting access to at least a portion of the artificial sensory experience.

45. The system of claim 43 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for granting access to at least a portion of the artificial sensory experience.

46. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent.

47. The system of claim 46 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a color scheme of an artificial sensory experience to modify at least one effect of the bioactive agent.

48. The system of claim 46 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering at least a portion of text of an artificial sensory experience to modify at least one effect of the bioactive agent.

49. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a sound in an artificial sensory experience.

50. The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of music in the artificial sensory experience.

51. The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of ambient noise in the artificial sensory experience.

52. The system of claim 49 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of voice in the artificial sensory experience.

53. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience to enhance the efficacy of the bioactive agent.

54. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience to reduce a side effect of the bioactive agent.

55. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for adding at least one of visual or audio content to the artificial sensory experience.

56. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for deleting at least one of visual or audio content of the artificial sensory experience.

57. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for adding content to the artificial sensory experience and deleting different content of the artificial sensory experience.

58. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a sensate experience to modify the at least one effect of the bioactive agent.

59. The system of claim 58 wherein the means for altering a sensate experience to modify the at least one effect of the bioactive agent comprises:

means for altering at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus to modify the at least one effect of the bioactive agent.

60. The system of claim 32 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience implemented on a mobile device.

61. The computer-implemented method of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:

means for detecting at least one of a pain medication, an antianxiety medication, an anti-addiction medication, an anti-obesity medication, or a mood-altering medication prescribed for the individual and altering an artificial sensory experience to modify at least one effect of the bioactive agent.

62. The system of claim 32 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:

means for detecting an anti-depressant medication in the individual and adding at least one cheerful attribute to a virtual world experience to increase an anti-depressive effect of the anti-depressant medication.

63. A system comprising:

circuitry for detecting at least one indication of bioactive agent use by an individual; and

circuitry for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

64. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for detecting at least one indication of bioactive agent use by an individual; and

one or more instructions for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

65. The computer program product of claim 64, wherein the signal-bearing medium includes a computer-readable medium.

66. The computer program product of claim 64, wherein the signal-bearing medium includes a recordable medium.

67. The computer program product of claim 64, wherein the signal-bearing medium includes a communications medium.

68. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

detect at least one indication of bioactive agent use by an individual; and

alter an artificial sensory experience to modify at least one effect of the bioactive agent.

69. The system of claim 68 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

70. The system of claim 68, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.